BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19911117)

  • 1. Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability.
    Baum L; Chan IH; Cheung SK; Goggins WB; Mok V; Lam L; Leung V; Hui E; Ng C; Woo J; Chiu HF; Zee BC; Cheng W; Chan MH; Szeto S; Lui V; Tsoh J; Bush AI; Lam CW; Kwok T
    Biometals; 2010 Feb; 23(1):173-9. PubMed ID: 19911117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxic effects of aluminium among foundry workers and Alzheimer's disease.
    Polizzi S; Pira E; Ferrara M; Bugiani M; Papaleo A; Albera R; Palmi S
    Neurotoxicology; 2002 Dec; 23(6):761-74. PubMed ID: 12520766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.
    Tully AM; Roche HM; Doyle R; Fallon C; Bruce I; Lawlor B; Coakley D; Gibney MJ
    Br J Nutr; 2003 Apr; 89(4):483-9. PubMed ID: 12654166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
    DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
    Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.
    Ritchie CW; Bush AI; Mackinnon A; Macfarlane S; Mastwyk M; MacGregor L; Kiers L; Cherny R; Li QX; Tammer A; Carrington D; Mavros C; Volitakis I; Xilinas M; Ames D; Davis S; Beyreuther K; Tanzi RE; Masters CL
    Arch Neurol; 2003 Dec; 60(12):1685-91. PubMed ID: 14676042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
    Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
    Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated cortical zinc in Alzheimer disease.
    Religa D; Strozyk D; Cherny RA; Volitakis I; Haroutunian V; Winblad B; Naslund J; Bush AI
    Neurology; 2006 Jul; 67(1):69-75. PubMed ID: 16832080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study.
    Ozcankaya R; Delibas N
    Croat Med J; 2002 Feb; 43(1):28-32. PubMed ID: 11828555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.
    Squitti R; Barbati G; Rossi L; Ventriglia M; Dal Forno G; Cesaretti S; Moffa F; Caridi I; Cassetta E; Pasqualetti P; Calabrese L; Lupoi D; Rossini PM
    Neurology; 2006 Jul; 67(1):76-82. PubMed ID: 16832081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum histamine in Alzheimer's disease and multi-infarct dementia.
    Cacabelos R; Fernández-Novoa L; Pérez-Trullén JM; Franco-Maside A; Alvarez XA
    Methods Find Exp Clin Pharmacol; 1992 Nov; 14(9):711-5. PubMed ID: 1294859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of arsenic, selenium, zinc, iron and copper in the urine of blackfoot disease patients at different clinical stages.
    Wang CT
    Eur J Clin Chem Clin Biochem; 1996 Jun; 34(6):493-7. PubMed ID: 8831051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased plasma antioxidants in patients with Alzheimer's disease.
    Kim TS; Pae CU; Yoon SJ; Jang WY; Lee NJ; Kim JJ; Lee SJ; Lee C; Paik IH; Lee CU
    Int J Geriatr Psychiatry; 2006 Apr; 21(4):344-8. PubMed ID: 16534775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
    Peng S; Wuu J; Mufson EJ; Fahnestock M
    J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease.
    Oudshoorn C; Mattace-Raso FU; van der Velde N; Colin EM; van der Cammen TJ
    Dement Geriatr Cogn Disord; 2008; 25(6):539-43. PubMed ID: 18503256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.
    Watanabe T; Miyazaki A; Katagiri T; Yamamoto H; Idei T; Iguchi T
    J Am Geriatr Soc; 2005 Oct; 53(10):1748-53. PubMed ID: 16181175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.
    Basun H; Forssell LG; Wetterberg L; Winblad B
    J Neural Transm Park Dis Dement Sect; 1991; 3(4):231-58. PubMed ID: 1772577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
    Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
    Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma levels of soluble CD40 in incipient Alzheimer's disease.
    Buchhave P; Janciauskiene S; Zetterberg H; Blennow K; Minthon L; Hansson O
    Neurosci Lett; 2009 Jan; 450(1):56-9. PubMed ID: 18996438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased midkine levels in sera from patients with Alzheimer's disease.
    Salama RH; Muramatsu H; Shimizu E; Hashimoto K; Ohgake S; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Okada S; Iyo M; Muramatsu T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):611-6. PubMed ID: 15866365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.